Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-A Olaussen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscapeK A Olaussen, S Postel-Vinay
Revue Des Maladies Respiratoires|April 21, 2010
[ERCC1 and lung cancer]D Planchard, K-A Olaussen, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapyB Besse, C Massard, V Haddad, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2005
Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLCK A Olaussen, J-C Soria, Y W Park, et al.
Oncogene|September 15, 2009
Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell linesK A Olaussen, F Commo, M Tailler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2008
Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesionsC M Raynaud, S J Jang, P Nuciforo, et al.
Oncogene|August 13, 2013
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancerS Postel-Vinay, I Bajrami, L Friboulet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancerJ Michels, J Adam, A Goubar, et al.
Oncogene|April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndromeS Boehrer, L Adès, N Tajeddine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclassesW E Pierceall, K A Olaussen, V Rousseau, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscapeK A Olaussen, S Postel-Vinay
Revue Des Maladies Respiratoires|April 21, 2010
[ERCC1 and lung cancer]D Planchard, K-A Olaussen, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapyB Besse, C Massard, V Haddad, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2005
Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLCK A Olaussen, J-C Soria, Y W Park, et al.
Oncogene|September 15, 2009
Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell linesK A Olaussen, F Commo, M Tailler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2008
Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesionsC M Raynaud, S J Jang, P Nuciforo, et al.
Oncogene|August 13, 2013
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancerS Postel-Vinay, I Bajrami, L Friboulet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancerJ Michels, J Adam, A Goubar, et al.
Oncogene|April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndromeS Boehrer, L Adès, N Tajeddine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclassesW E Pierceall, K A Olaussen, V Rousseau, et al.
Pageof 2